How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

13,996 results for

E/M Medical Decision Making

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Lung cancer: NCCP advice for medical professionals on the management of patients undergoing Lung Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) pandemic

staff and infrastructure, and as a result will implement this advice based on their own unique circumstances. The purpose of this advice is to maximise the safety of patients and make the best use of HSE resources, while protecting staff from infection. It will also enable services to match the capacity for cancer care to patient needs if services become limited due to the COVID-19 pandemic. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement (...) , R., Faivre-Finn, C., Flentje, M., Gore, E. and Higgins, K.A., 2020. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiotherapy and Oncology. 6 Seto, T., Takahashi, T., Yamanaka, T., Harada, H., Nokihara, H., Saka, H., Nishio, M., Nakagawa, K., Takayama, K., Ishimoto, O. and Takeda, K., 2014. Prophylactic cranial irradiation (PCI) has a detrimental effect on the overall survival (OS) of patients (pts) with extensive disease

2020 Health Service Executive (Ireland) - Clinical Guidelines

122. CNS cancer: NCCP advice for medical professionals on the treatment of patients with CNS tumours with radiotherapy in response to the COVID-19 pandemic

will implement this advice based on their own unique circumstances. The purpose of this advice is to maximise the safety of patients and make the best use of HSE resources, while protecting staff from infection. It will also enable services to match the capacity for cancer care to patient needs if services become limited due to the COVID-19 pandemic. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances (...) with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The Lancet Oncology, 10(5), pp.459-466. 6. Perry, J.R., Laperriere, N., O’Callaghan, C.J., Brandes, A.A., Menten, J., Phillips, C., Fay, M., Nishikawa, R., Cairncross, J.G., Roa, W. and Osoba, D., 2017. Short-course radiation plus temozolomide in elderly patients with glioblastoma. New England Journal of Medicine, 376(11), pp.1027-1037. 7

2020 Health Service Executive (Ireland) - Clinical Guidelines

123. Covid-19: Guidance review for emergency medical dispatch centres

England, (27) the Pre-Hospital Emergency Care Council of Ireland, (26) the Indian Ministry of Health, (29) the Chinese National Health Commission, (28) the European Society for Emergency Medicine, (19) the Collaborative Coalition for International Public Safety, (18) and the International Liaison Committee on Resuscitation. (11) Review of guidance for the operation of emergency medical dispatch centres Health Information and Quality Authority Page 8 of 82 Guidance content: relevance Seven documents (...) of emergency medical dispatch centres Health Information and Quality Authority Page 14 of 82 and patients. (3) The PTAC was co-located with the Toronto EMS Central Ambulance Communications Centre (CACC) at Toronto EMS headquarters centre. Managers reassigned paramedic supervisors, dispatchers, and support staff to operate the centre. Staff began collating incoming transfer requests, answering telephones, and processing requests based on a decision algorithm designed to determine which transfers could

2020 Health Information and Quality Authority

124. Treatment of mucopolysaccharidosis type II (Hunter syndrome): a Delphi derived practice resource of the American College of Medical Genetics and Genomics (ACMG) (includes supplemental material)

recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis. 2011;6:72. 19. Gonzalez-Gutierrez-Solana L, Guillen-Navarro E, Del Toro M, Dalmau J, Gonzalez-Meneses A, Couce ML. Diagnosis and follow-up of patients with Hunter syndrome in Spain: a Delphi consensus. Medicine (Baltimore). 2018;97:e11246. 20. da Silva EM, Strufaldi MW, Andriolo RB, Silva LA. Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome). Cochrane (...) Department of Pediatrics, College of Medicine, Ohio State University, Columbus, OH, USA; 3 Division of Genetics and Metabolism, Departments of Pediatrics and Genetics, Cell Biology & Development, University of Minnesota, Minneapolis, MN, USA; 4 Department of Human Genetics and Pediatrics, McGill University, Montreal, QC, Canada; 5 Division of Medical Genetics, McGill University Health Center, Montreal, QC, Canada; 6 American College of Medical Genetics and Genomics, Bethesda, MD, USA. Correspondence

2020 American College of Medical Genetics and Genomics

125. Medical scientists and philosophers worldwide appeal to EBM to expand the notion of ‘evidence’ Full Text available with Trip Pro

. In particular, if we are to understand what is meant by ‘evidence’, what is the ‘best available evidence’ and how to apply it in the context of medicine, we need to tackle the problem of causation head on. In practice, this means understanding the context in which evidence is obtained, as well as how the evidence might be interpreted and applied when making practical clinical decisions. It also means being explicit about what kind of causal knowledge can be gained through various research methods (...) References 1. Clarke B , Gillies D , Illari P , et al . The evidence that evidence-based medicine omits . 2. Aronson JK , La Caze A , Kelly MP , et al . The use of mechanistic evidence in drug approval . 3. Parkkinen V-P , Wallmann C , Wilde M , et al . Evaluating evidence of mechanisms in medicine: principles and procedures : Springer , 2018 . 4. Osimani B . Hunting side effects and explaining them: should we reverse evidence hierarchies upside down? 5. Rocca E . The judgement that evidence based

2020 Evidence-Based Medicine

126. Appropriate Use Criteria: Nuclear Medicine Imaging

32 Nuclear Medicine Imaging Copyright © 2020. AIM Specialty Health. All Rights Reserved. 3 References 33 Codes 37 History 40 Nuclear Medicine Imaging Copyright © 2020. AIM Specialty Health. All Rights Reserved. 4 Description and Application of the Guidelines The AIM Clinical Appropriateness Guidelines (hereinafter “the AIM Clinical Appropriateness Guidelines” or the “Guidelines”) are designed to assist providers in making the most appropriate treatment decision for a specific clinical condition (...) medical practice should be used when applying the Guidelines. Guideline determinations are made based on the information provided at the time of the request. It is expected that medical necessity decisions may change as new information is provided or based on unique aspects of the patient’s condition. The treating clinician has final authority and responsibility for treatment decisions regarding the care of the patient and for justifying and demonstrating the existence of medical necessity

2020 AIM Specialty Health

127. Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America Full Text available with Trip Pro

Search for other works by this author on: , Michael A Horberg Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic Permanente Medical Group , Rockville, Maryland, USA Correspondence: M. A. Horberg, Kaiser Permanente Mid-Atlantic Permanente Medical Group and Care Management Institute, 2101 East Jefferson Street, 3 East, Rockville, MD 20852 ( ). Search for other works by this author on: , Allison L Agwu Division of Infectious Diseases, Johns Hopkins University School of Medicine (...) , Baltimore, Maryland, USA Search for other works by this author on: , Jonathan A Colasanti Division of Infectious Diseases, Emory University , Atlanta, Georgia, USA Search for other works by this author on: , Mamta K Jain Division of Infectious Diseases, University of Texas Southwestern Medical Center , Dallas, Texas, USA Search for other works by this author on: , William R Short Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania, USA

2020 Infectious Diseases Society of America

128. The Nurse’s Role When a Patient Requests Medical Aid in Dying

Adopted by: ANA Board of Directors Purpose The purpose of this position statement is to provide guidance on ethical decision-making in response to a patient’s request for medical aid in dying. This statement offers assistance with understanding nurses’ ethical obligations in the context of this end-of-life option, which is legal in an increasing number of U.S. jurisdictions. This position statement recognizes that there are a plurality of views on the issue, that there is a paucity of available (...) and the capacity for medical decision-making to self-administer oral or enteral medication when certain criteria are met. Euthanasia, which is not legal in the United States, occurs when someone other than the patient administers medication in any form with the intention of hastening the patient’s death. Euthanasia is inconsistent with the core commitments of the nursing profession and profoundly violates public trust. The The Nurse’s Role When a Patient Requests Medical Aid in Dying 8515 Georgia Avenue, Suite

2020 Oncology Nursing Society Putting Evidence into Practice (PEP)

129. Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) Full Text available with Trip Pro

, Chaberny I, Mousset S, Buchheidt D, Ruhnke M, Penack O, Salwender H, Wolf HH, Christopeit M, Neumann S, Maschmeyer G, Karthaus M; Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology. Hentrich M, et al. Ann Oncol. 2014 May;25(5):936-47. doi: 10.1093/annonc/mdt545. Epub 2014 Jan 7. Ann Oncol. 2014. PMID: 24399078 Penack O, Becker C, Buchheidt D, Christopeit M, Kiehl M, von Lilienfeld-Toal M, Hentrich M, Reinwald M, Salwender H, Schalk E, Schmidt-Hieber M, Weber T (...) -related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Department I of Internal Medicine, Hematology and Oncology, Intensive Care Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Strasse 62, 50937, Cologne

2021 German Clinical Guidelines

130. Simplified guideline for prescribing medical cannabinoids in primary care

Simplified guideline for prescribing medical cannabinoids in primary care Vol 64: FEBRUARY | FÉVRIER 2018 | Canadian Family Physician | Le Médecin de famille canadien 111 CLINICAL PRACTICE GUIDELINES Abstract Objective To develop a clinical practice guideline for a simplified approach to medical cannabinoid use in primary care; the focus was on primary care application, with a strong emphasis on best available evidence and a promotion of shared, informed decision making. Methods The Evidence (...) , and content is offered to support shared, informed decision making. Conclusion This simplified medical cannabinoid prescribing guideline provides practical recommendations for the use of medical cannabinoids in primary care. All recommendations are intended to assist with, not dictate, decision making in conjunction with patients. Editor’s key points ? This simplified prescribing guideline was developed with a primary care focus. Guideline contributors were selected based on profession, practice setting

2018 CPG Infobase

131. A resource for developing an evidence synthesis report for policy-making

A resource for developing an evidence synthesis report for policy-making Leena Eklund Karlsson | Ryoko Takahashi HEALTH EVIDENCE NETWORK SYNTHESIS REPORT 50 A resource for developing an evidence synthesis report for policy-makingThe Health Evidence Network HEN – the Health Evidence Network – is an information service for public health decision-makers in the WHO European Region, in action since 2003 and initiated and coordinated by the WHO Regional Office for Europe under the umbrella (...) of the European Health Information Initiative (a multipartner network coordinating all health information activities in the European Region). HEN supports public health decision-makers to use the best available evidence in their own decision-making and aims to ensure links between evidence, health policies and improvements in public health. The HEN synthesis report series provides summaries of what is known about the policy issue, the gaps in the evidence and the areas of debate. Based on the synthesized

2017 WHO Health Evidence Network

132. Medical management of abortion

the option of starting hormonal contraception immediately after the first pill of the medical abortion regimen. Notes: • All individuals who can become pregnant should be provided with all of the necessary information to make an informed decision regarding the use of contraception. Immediate initiation of intramuscular (IM) depot medroxyprogesterone acetate (DMPA) is associated with a slight decrease in the effectiveness of medical abortion regimens (67). However, immediate initiation of DMPA should (...) still be offered as an available contraceptive method after an abortion. • Indirect evidence was used as a basis for decision-making on initiation of hormonal contraception as an option for individuals undergoing medical abortion with misoprostol alone. • No data were available on the use of combined hormonal contraception (pills or injections) by those undergoing medical abortion. RECOMMENDATION TYPE: NEW OR UPDATED Recommendation 4a is a new recommendation. 3.5.2 Timing of post-abortion

2019 World Health Organisation Guidelines

133. Breast Cancer: Medication Use to Reduce Risk

B. Caughey, MD, PhD (Oregon Health & Science University, Portland); Chyke A. Doubeni, MD, MPH (Mayo Clinic, Rochester, MN); John W. Epling Jr, MD, MSEd (Virginia Tech Carilion School of Medicine, Roanoke); Martha Kubik, PhD, RN (Temple University, Philadelphia, Pennsylvania); C. Seth Landefeld, MD (University of Alabama at Birmingham); Carol M. Mangione, MD, MSPH (University of California, Los Angeles); Lori Pbert, PhD (University of Massachusetts Medical School, Worcester); Michael Silverstein (...) and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms. Importance

2019 U.S. Preventive Services Task Force

134. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication

of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms. Importance In the United States, the rate of gonococcal (...) K. Owens, MD, MS (Veterans Affairs Palo Alto Health Care System, Palo Alto, California, and Stanford University, Stanford, California); Michael J. Barry, MD (Harvard Medical School, Boston, Massachusetts); Aaron B. Caughey, MD, PhD (Oregon Health & Science University, Portland); Karina W. Davidson, PhD, MASc (Columbia University, New York, New York); Chyke A. Doubeni, MD, MPH (University of Pennsylvania, Philadelphia); John W. Epling Jr, MD, MSEd (Virginia Tech Carilion School of Medicine

2019 U.S. Preventive Services Task Force

135. Patient-centered Outcomes Research in Pulmonary, Critical Care, and Sleep Medicine: A Workshop Report

communication and shared decision making Truth, relevance, and content validity Patients involved from inception identi?ed research questions, reviewed PROMIS tools, helped monitor recruitment, interpreted results, and identi?ed relevance/ dissemination for different groups Effects on communication and medical decision making Ability to detect change and discrimination “Value” and implication of study results De?nition of abbreviations: PRO=patient-reported outcomes; PROMIS=Patient-Reported Outcomes (...) . Correspondence and requests for reprints should be addressed to Erin K. Kross, M.D., Division of Pulmonary and Critical Care, University of Washington, Harborview Medical Center, 325 9th Avenue, Box 359762, Seattle, WA 98104. E-mail: ekross@uw.edu. This article has an online supplement, which is accessible from this issue’s table of contents at www.atsjournals.org. Ann Am Thorac Soc Vol 15, No 9, pp 1005–1015, Sep 2018 Copyright© 2018 by the American Thoracic Society DOI: 10.1513/AnnalsATS.201806-406WS

2019 American Thoracic Society

136. High-Throughput Sequencing in Respiratory, Critical Care, and Sleep Medicine Research Full Text available with Trip Pro

, Critical Care, and Sleep Medicine Research. An Official American Thoracic Society Workshop Report x Craig P. Hersh , x Ian M. Adcock , x Juan C. Celedón , x Michael H. Cho , x David C. Christiani , x Blanca E. Himes , x Naftali Kaminski , x Rasika A. Mathias , x Deborah A. Meyers , x John Quackenbush , x Susan Redline , x Katrina A. Steiling , x Holly K. Tabor , x Martin D. Tobin , x Mark M. Wurfel , x Ivana V. Yang , and x Gerard H. Koppelman ; on behalf of the American Thoracic Society Section (...) uackenbush , P h .D. 15 S usan R edline , M.D., M.P.H. 3,16,17 K atrina A. S teiling , M.D., M.S c . 18 H olly K. T abor , P h .D. 19 M artin T obin , P h .D., M.B.C h .B. 20,21 M ark M. W urfel , M.D., P h .D. 22 I vana V. Y ang , P h .D. 23 1 Channing Division of Network Medicine, 2 Division of Pulmonary and Critical Care Medicine, and 16 Division of Sleep and Circadian Disorders, Brigham and Women’s Hospital, Boston, Massachusetts; 3 Harvard Medical School, Boston, Massachusetts; 4 Department

2019 American Thoracic Society

137. American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation Full Text available with Trip Pro

and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina Correspondence Reprint requests Address requests for reprints to: Seth D. Crockett, MD, MPH, Division of Gastroenterology and Hepatology, University of North Carolina, CB 7080, 130 Mason Farm Road, Chapel Hill, North Carolina 27599. fax: (919) 966-8929. , x Katarina B. Greer Affiliations Division of Gastroenterology and Liver Disease, University Hospitals Cleveland Medical Center, Cleveland, Ohio 2 , x Joel J (...) . Heidelbaugh Affiliations Departments of Family Medicine and Urology, University of Michigan Medical School, Ann Arbor, Michigan 3 , x Yngve Falck-Ytter Affiliations Division of Gastroenterology, Case Western Reserve University and Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio 4 , x Brian J. Hanson Affiliations Division of Gastroenterology, University of Minnesota and Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota 5 , x Shahnaz Sultan Affiliations Division

2019 American Gastroenterological Association Institute

138. Principles of Pediatric Patient Safety: Reducing Harm Due to Medical Care

in office care (7%); together, these errors comprised 80% of all reports. In this practice, a voluntary, nonpunitive, multidisciplinary team approach was effective in improving error reporting, investigating causes of reported errors, and implementing safety promotion strategies. In addition to these setting-specific errors, the National Academies of Sciences, Engineering, and Medicine has turned attention to diagnostic decision-making as perhaps the most frequent source of medical error. Errors (...) . Cottrell EK , O’Brien K , Curry M , et al . Understanding safety in prehospital emergency medical services for children. O’Neill KA , Shinn D , Starr KT , Kelley J . Patient misidentification in a pediatric emergency department: patient safety and legal perspectives. Heilman JA , Flanigan M , Nelson A , Johnson T , Yarris LM . Adapting the I-PASS handoff program for emergency department inter-shift handoffs. Shahian DM , McEachern K , Rossi L , Chisari RG , Mort E . Large-scale implementation of the I

2019 American Academy of Pediatrics

139. Appropriate prescribing of psychotropic medication for non-cognitive symptoms in people with dementia

for depression in a person with dementia 68 3.5 Anticonvulsant medication 69 3.5.1 Carbamazepine 69 3.5.2 Gabapentin 69 3.5.3 Sodium valproate 70 3.5.4 Lamotrigine 70 3.5.5 Summary of evidence and recommendations for anticonvulsant medication 70 3.6 Benzodiazepines 71 3.7 Z-drugs (hypnotics) and melatonin 73 3.8 Supporting decision making with regards to psychotropic medication 75 3.8.1 What information must be discussed? 75 3.8.2 Capacity of person to make decisions 75 3.8.3 Making decisions if capacity (...) will and preferences concerning treatment decisions that may arise in respect of him or her if he or she subsequently lacks capacity, and (b) in relation to a designated healthcare representative, means the advanced expression under which the representative was designated as such representative (Assisted Decision-Making (Capacity) Act, 2015). Adverse effects An undesired harmful effect resulting from a medication or other intervention. Aggression Feelings of anger or antipathy resulting in hostile or violent

2019 National Clinical Guidelines (Ireland)

140. Immediate postpartum long-acting reversible contraception for women at high risk for medical complications Full Text available with Trip Pro

Immediate postpartum long-acting reversible contraception for women at high risk for medical complications SocietyforMaternal-FetalMedicine(SMFM) ConsultSeries#48:Immediatepostpartum long-actingreversiblecontraceptionforwomen athighriskformedicalcomplications Society for Maternal-Fetal Medicine (SMFM); Laura K. Vricella, MD; Lori M. Gawron, MD, MPH; Judette M. Louis, MD, MPH The Society of Family Planning (SFP) endorses this document. The American College of Obstetricians and Gynecologists (...) , and appropriatelybillforservices.Expandingtherangeofhealth- careprofessionalswhoaretrainedtocounselwomenandto insertLARCdevicescouldreducetheburdenonphysicians. ProgramstotrainnursesormidwivesinLARCcounselingas wellasplacementmaybeamodelthatcanbeintegratedinto busy outpatient and inpatient settings. The MFM subspe- cialist can serve as consultant for these teams to help with contraceptive decision making for women with complex medical conditions. Having obstetric care provider cham- pionscanleadtoimplementationofsustainableprogramsin

2019 Society for Maternal-Fetal Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>